What is the main topic?

The article discusses the growth of the Contrast Media Injectors market, projected to grow at a 4.9% CAGR through 2030.

How is AI impacting the market?

AI is expected to speed up the process of injecting contrast media, enhancing market growth.

Which region is leading the market?

North America is expected to be the most lucrative region, accounting for over 32% of the market share in 2020.

Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Research Reports > Contrast Media Injectors Market is likely to grow at over 4.9% through 2020-2030

Research Reports

Contrast Media Injectors Market is likely to grow at over 4.9% through 2020-2030

Published by Uma Rajagopal

Posted on January 6, 2022

3 min read

Last updated: January 28, 2026

Two Romanian men arrested in London for attacking British-Iranian journalist - Global Banking & Finance Review — The image depicts the arrest of two Romanian suspects in London linked to the stabbing of British-Iranian journalist Pouria Zeraati. This event highlights concerns over Iran's influence and criminal activities abroad, pivotal in today's finance and security discussions.

Contrast Media Injectors Market to Grow Over 4.9% by 2030

FMI, an ESOMAR-certified market research firm, estimates global contrast media injectors market revenues to reach US$ 1.2 Bn in 2020. In its new study, FMI takes a long-term optimistic view of the market, estimating global revenues to grow at 4.9% CAGR through 2030. The report opines that AI’s growing penetration in the healthcare sector will also rub off on contrast media injectors industry during the next decade.

Key Takeaways of Contrast Media Injectors Market Study

North America is expected to be the most lucrative region and account for more than 32% of revenue in the global contrast media injectors in 2020 and this trend is expected to continue during the forecast period

Larger patient pool and increasing government support towards developing healthcare system in Asian countries are expected to propel the growth of the contrast media injectors market in the region

AI is expected to speed up the process of injecting contrast media in the forecast period

Increasing applications in orthopedic surgeries and neurosurgeries to bolster the market in the forecast period

New Product Launches and Approval – The Ongoing Trend

The market players are into getting their new products launched as well as approved to stay in the competition and also keep pace with the market scenario (that of continuing to innovate). The constructive steps in this regard are:

In Apr 2020, Guerbet announced getting approved by the US FDA for manufacturing gadoterate meglumine (Dotarem) injection inside the US. Till late 2019, this production used to happen outside of the US.

In Nov 2019, the US FDA approved an MRI contrast agent “Clariscan” for intravenous use in spine, brain (intracranial), and associated tissues.

In Aug 2019, Bracco Diagnostics, Inc. announced getting approved by the US FDA for oral suspension of barium sulfate (Varibar Thin Liquid). The basic use of this contrast agent is detection and assessment of dysphagia.

What else is in the report?

Future market insights offer actionable insights and unique perspective on contrast media injectors market in its latest study, presenting historical demand assessment from 2015 – 2019 and projections from 2020–2030 based on product type (angiographic injectors, magnetic resonance imaging (MRI) injectors, computed tomography (CT) injectors), by end-user (hospital, ambulatory surgical centres, diagnostics centres) in seven key regions

Contrast Media Injectors Market is likely to grow at over 4.9% through 2020-2030

Quick Summary

Contrast Media Injectors Market to Grow Over 4.9% by 2030

Key Takeaways

Frequently Asked Questions about Contrast Media Injectors Market is likely to grow at over 4.9% through 2020-2030